Cargando…
Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cells
BACKGROUND: Uveitis is a potentially blinding inflammatory disease of the inner eye with a high unmet need for new therapeutic interventions. Here, we wanted to investigate the suppressive effect of the intraocular application of the small molecule dihydroorotate dehydrogenase (DHODH)-inhibitor PP-0...
Autores principales: | Diedrichs-Möhring, Maria, Niesik, Sandy, Priglinger, Claudia S., Thurau, Stephan R., Obermayr, Franz, Sperl, Stefan, Wildner, Gerhild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822610/ https://www.ncbi.nlm.nih.gov/pubmed/29467002 http://dx.doi.org/10.1186/s12974-018-1088-6 |
Ejemplares similares
-
A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis — A phase I clinical trial
por: Thurau, Stephan, et al.
Publicado: (2022) -
Dynamics of Intraocular IFN-γ, IL-17 and IL-10-Producing Cell Populations during Relapsing and Monophasic Rat Experimental Autoimmune Uveitis
por: Kaufmann, Ulrike, et al.
Publicado: (2012) -
Molecular Mimicry and Uveitis
por: Wildner, Gerhild, et al.
Publicado: (2020) -
Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022) -
CRALBP is a Highly Prevalent Autoantigen for Human Autoimmune Uveitis
por: Deeg, Cornelia A., et al.
Publicado: (2007)